November 2nd, 2009: Maxwell Render 2.0 support announced
From now on REBUSfarm supports Maxwell Render in its newest version 2.0. Of course we are still supporting the older version 1.7.1 as well. The REBUSfarm is fully licensed and by far the biggest rendering service for Maxwell Render, so your Maxwell project can take advantage of the full power of the farm, meaning 3700 GHz or 236 render clients.
To open this offer to the Maxwell community we are having a very special promo: From 02.11.2009 to 30.12.2009 Maxwell users only pay half of the regular price, which is only 4.95 cent / GHzh instead of 9.9 cent /GHzh. Since Maxwell users benefit from the 10 EUR free trial as well, you will get an equivalent of 14 hours render time on a Intel Q6600 for free. Only that you will get your result in only a few minutes...
Feel free to test our system. Just create a new account and use the 10 EUR free trial.
About Next Limit Technologies
Since its foundation in Madrid in 1998 by Victor Gonzales and Ignaco Vargas, Next Limit Technologies developed software such as RealFlow, Maxwell Render and XFlow. Development is focused on making use of physical knowledge, and integrating it into the field of 3D visualization. RealFlow is a liquid- and physics-simulation, while Maxwell Render acts as a physics-based light-simulator. All software-products are available for several platforms and integrate with the most known DCC and CAD applications.
About REBUSfarm
REBUSfarm is a spin-off to REBUSmedia (see www.rebusmedia.net. The company has been founded in Cologne in 2006, by André Konnopasch and Ralph Huchtemann, and leads the market in Europe. REBUSfarm aims at fulfilling the growing need of rendering power in the field of 3D-animation. REBUSfarm supports a wide range of 3D applications. This includes so-called host-applications, as well as secondary rendering applications. Furthermore REBUSfarm aims at offering the biggest possible rendering capacity at the most affordable price, while maintaining service oriented contact to the customer.